This inventor holds 1 USPTO granted patent. Top assignee: Bioventures, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Zhengyu Wang
Introduction
Zhengyu Wang is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative work on Mi-2β inhibitors. His research focuses on developing methods to combat cancer by utilizing these inhibitors effectively.
Latest Patents
Zhengyu Wang holds 1 patent for his invention titled "Mi-2β inhibitor as an immunotherapy agent." This patent discloses Mi-2β inhibitors and methods of using them. The methods involve administering an effective amount of a Mi-2β inhibitor to a subject or contacting a cancer cell or tumor with an effective amount of the inhibitor.
Career Highlights
Zhengyu Wang is currently associated with Bioventures, LLC, where he continues to advance his research in immunotherapy. His work is pivotal in exploring new avenues for cancer treatment, showcasing his dedication to improving patient outcomes.
Collaborations
Zhengyu Wang collaborates with esteemed colleagues, including Hong-yu Li and Jingwei Shao. Their combined expertise enhances the research efforts at Bioventures, LLC, fostering innovation in the field.
Conclusion
Zhengyu Wang's contributions to immunotherapy through his patent on Mi-2β inhibitors exemplify his commitment to advancing cancer treatment. His work not only highlights his innovative spirit but also underscores the importance of collaboration in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile